Psylink is a biotechnology company offering a novel solution to psychedelic drug development
Psylink has raised $579K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.
Psylink's investors include BSV Ventures, Coinvest Capital, FIRSTPICK.
Psylink is headquartered in Vilnius, Lithuania.
Psylink is a biotechnology company offering a novel solution to psychedelic drug development
Psylink is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Psylink — Funding & Investors." VCBacked, July 29, 2025, https://www.vcbacked.co/company/psylink. Accessed August 14, 2026.
VCBacked. (2025). Psylink — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/psylink
{{cite web |title=Psylink — Funding & Investors |url=https://www.vcbacked.co/company/psylink |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated